ABSTRACT
INTRODUCTION: Our aim was to assess impact of frailty on short-term clinical outcomes in critically ill patients with cancer. MATERIALS AND METHODS: We conducted a cohort study at a medical and surgical intensive care unit (ICU) in Argentina. We included 269 consecutive patients, ≥18 years old, with diagnosis of cancer. We recorded demographic and clinical characteristics, Clinical Frailty Scale (CFS, ≥5 defined a patient as frail), and the number and duration of organ support therapies during ICU stay. Primary outcome was ICU and hospital mortality. RESULTS: Median age 69 (range 20-90); 152 (56%) patients were male. Sixty-eight (25.2%) patients presented frailty at admission. Older adults (≥65 years old) made up 62.8% of patients. Frail patients were 69.7 years versus 64.4 years for non-frail, P = 0.007, with higher Acute Physiology and Chronic Health Evaluation II (APACHE II) 14.7 ± 7 versus 10.8 ± 6, P = 0.001 and Simplified Acute Physiology Score (SAPS II) 40.1 ± 17 versus 28.7 ± 14, P = 0.001, respectively. After adjusting by age, severity score, type of admission, and type of cancer, frailty was independently associated with hospital mortality, odds ratio (OR) 4.87 (95% confidence interval [CI], 2.19-11.19, P ≤0.001). Median ICU length of stay was five days (interquartile range [IQR] 3-7) versus six days (IQR 3.8-9), in non-frail versus frail patients, respectively (P = 0.100), and hospital stay was nine days (IQR 6-17) versus 11.5 days (IQR 7-19.5) in non-frail versus frail patients, respectively (P = 0.085). DISCUSSION: Frailty as a medical condition was strongly associated with worse clinical outcomes among oncologic critically ill patients.
Subject(s)
Frailty , Neoplasms , Humans , Male , Aged , Female , Frailty/diagnosis , Critical Illness/therapy , Cohort Studies , Prospective Studies , Intensive Care Units , Hospital Mortality , Length of Stay , Neoplasms/therapyABSTRACT
Se presenta un paciente de 27 años, portadora de enfermedad de Still del adulto, que desarrolló un síndrome de activación macrofágica de evolución fatal. Se revisan ambos cuadros, las manifestaciones clínicas y los resultados de los estudios complementarios
Subject(s)
Humans , Female , Adult , CD8-Positive T-Lymphocytes , Macrophage Activation , Magnetic Resonance Imaging , Still's Disease, Adult-OnsetABSTRACT
Se presenta un paciente de 27 años, portadora de enfermedad de Still del adulto, que desarrolló un síndrome de activación macrofágica de evolución fatal. Se revisan ambos cuadros, las manifestaciones clínicas y los resultados de los estudios complementarios(AU)
